Pharma Marketing Network

DECEMBER 17, 2021

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Health for Humanity 2025 Goals.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

pharmaphorum

OCTOBER 13, 2022

However, patent protection remains in some major markets, including France, Italy, Spain, and the UK until 2025. The question is whether other major pharmaceutical companies will be attracted to the space – particularly when areas such as oncology and orphan drugs currently provide a larger return on investment.

Biosimilars 98

Biosimilars Communication Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues.

Compounding 98

Compounding Communication Pharmaceutical Companies Pharmaceutical Companies 98

Viseven

AUGUST 29, 2024

Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. As this trend unfolds, it is vital to understand the benefits 5G brings, how it impacts healthcare communication , and how healthcare businesses can leverage it. What Is 5G?

Communication 52

Communication Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

PharmaState Academy

DECEMBER 18, 2024

This quiz competition is brought to you by Now & Next Summit on Pharma Marketing | Edition 2 scheduled for 18th Jan 2025 at Jio World Convention Centre, BKC, Mumbai. Name Email Phone Number Company Department Designation 1 / 20 What is the primary goal of scientific communication in Pharma Marketing? How to Participate?

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

MARCH 12, 2021

Behind all of these are massive and growing volumes of data that life sciences companies generate, manage and analyse to secure breakthroughs. One estimate [1] suggests that by 2025 more than 60 million patients will have their genome sequenced. And those volumes will only increase.

Vaccines 111

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 111

Pharmaceutical Technology

JUNE 19, 2023

Pharmaceutical companies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide.

Packaging 52

Packaging Compounding Communication Pharmaceutical Companies 52

Viseven

JANUARY 4, 2023

From life-saving drugs discovery, development, and production to clinical trials, communication, and drug target identification — AI pharmaceutical is a definite game-changer. The post The Use of Artificial Intelligence in the Pharmaceutical Industry appeared first on Viseven.

Drug Development 52

Drug Development Medical Records Communication Pharmaceutical Companies 52

pharmaphorum

APRIL 19, 2022

“In a situation where most of the development of treatments in Korea is mostly centred on cancer and metabolic diseases, I noticed that there weren’t any companies that were focusing on sensory diseases.”. Kim says the Dry Eye Disease market is large and growing, with analysts predicting it will hit $6 billion USD by 2025.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

Pharmaceutical Technology

APRIL 25, 2023

A few months later, the board of the nonprofit Vaccine Alliance Gavi approved an initial investment of nearly $160 million, to be given between 2022 and 2025, to support the rollout of the malaria vaccine in GAVI-eligible countries. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements.

Vaccines 69

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 69

Pharmaceutical Technology

MARCH 22, 2023

Large-molecule drugs such as biologics are particularly sensitive to foreign contamination and E&L interaction, making these issues key concerns for pharmaceutical companies. From 2025, it will be substituted with a new chapter on functional tests for the complete system.” Please check your email to download the Webinar.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

MARCH 28, 2025

Suven Pharmaceuticals announced that the National Company Law Tribunal (NCLT), vide its order pronounced on March 27, 2025, has sanctioned the Scheme of Amalgamation between Cohance Lifesciences and Suven Pharmaceuticals. As previously communicated, the Company expects to complete the amalgamation process by Q1FY26.

Communication 90

Communication Pharmaceutical Companies Pharmaceutical Companies 90

Pharmaceutical Technology

APRIL 24, 2023

Meanwhile, the Indian biologics market is expected to grow to $12 billion by 2025, with a compound annual growth rate (CAGR) of 22%. As a result, some pharmaceutical companies are turning to third parties. Moreover, skilled manpower is required to run these facilities. Please check your email to download the Whitepaper.

Vaccines 52

Vaccines Compounding Communication Immunity 52

Pharmaceutical Technology

DECEMBER 22, 2022

The new joint procedure will launch in Q1 2025 for oncology medicines and other advanced therapy medicinal products and extend to orphan drugs in 2028. By 2030, JCAs will be carried out on all medicinal products with an EMA-issued MA. Will the joint procedure drive positive change? Please check your email to download the Case Study.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Communication 52